Viewing Study NCT06894693


Ignite Creation Date: 2025-12-25 @ 1:08 AM
Ignite Modification Date: 2026-03-13 @ 4:59 AM
Study NCT ID: NCT06894693
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-03-25
First Post: 2025-03-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase I Clinical Trial of RS001 in Patients with Relapsed/Refractory B-Cell Malignancies
Sponsor: Guangdong Ruishun Biotech Co., Ltd
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module